PEDIATRICS Vol. 117 No. 6 June 2006, pp. 1915-1921 (doi:10.1542/peds.2005-2294)
Expanded Newborn Screening for Biochemical Disorders: The Effect of a False-Positive Result
a Departments of Medicine
d Psychiatry
b Clinical Research Program, Children's Hospital Boston, Boston, Massachusetts
c Pediatrix/NeoGen, Bridgeville, Pennsylvania
BACKGROUND. Newborn screening programs now identify children with >30 biochemical genetic disorders. False-positive identifications may increase as disorders are added to screening panels. Concerns arise regarding the potential impact on parental stress, family relationships, and perceptions of the child's health.
METHODS. Parents of 173 infants with false-positive screening results for a biochemical genetic disorder in the expanded newborn screening panel were compared with parents of 67 children with normal screening results. Parents completed an interview that elicited information about demographic features, child and parental health, and understanding of newborn screening. Parents also completed the parenting stress index.
RESULTS. Parents in the false-positive group attained higher total scores on the PSI than did parents in the normal-screened group, scoring higher on the parent-child dysfunction subscale and the difficult child subscale. Only approximately one third of parents in the false-positive group reported knowing the correct reason for repeat screening. Mothers who reported knowing the correct reason for their child's repeat screening test experienced less total stress than did mothers who were misinformed, were not informed, or did not remember.
CONCLUSIONS. False-positive screening results may affect parental stress and the parent-child relationship. Improved communication with parents regarding the need for repeat screening tests may reduce the negative impact of false-positive results.
Key Words: newborn screening false-positive parental stress vulnerable child nocebo phenomenon parent-child relationship
Abbreviations: PKUphenylketonuria PSIparenting stress index
Accepted Nov 17, 2005.
This article has been cited by other articles:
![]() |
L. A. Prosser, J. A. Ladapo, D. Rusinak, and S. E. Waisbren Parental Tolerance of False-positive Newborn Screening Results Arch Pediatr Adolesc Med, September 1, 2008; 162(9): 870 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Bailey Jr, F. D. Armstrong, A. R. Kemper, D. Skinner, and S. F. Warren Supporting Family Adaptation to Presymptomatic and "Untreatable" Conditions in an Era of Expanded Newborn Screening J. Pediatr. Psychol., March 30, 2008; (2008) jsn032v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Vohr, J. Jodoin-Krauzyk, R. Tucker, M. J. Johnson, D. Topol, and M. Ahlgren Results of Newborn Screening for Hearing Loss: Effects on the Family in the First 2 Years of Life Arch Pediatr Adolesc Med, March 1, 2008; 162(3): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Bailey Jr, D. Skinner, A. M. Davis, I. Whitmarsh, and C. Powell Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues Pediatrics, March 1, 2008; 121(3): e693 - e704. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bishop Hubbard Policy Issues Related to Expanded Newborn Screening: A Review of Three Genetic/Metabolic Disorders Policy Politics Nursing Practice, August 1, 2007; 8(3): 201 - 209. [Abstract] [PDF] |
||||
![]() |
B. A. Tarini The Current Revolution in Newborn Screening: New Technology, Old Controversies Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Kerruish, P. L. Campbell-Stokes, A. Gray, T. R. Merriman, S. P. Robertson, and B. J. Taylor Maternal Psychological Reaction to Newborn Genetic Screening for Type 1 Diabetes Pediatrics, August 1, 2007; 120(2): e324 - e335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. la Marca, S. Malvagia, E. Pasquini, M. Innocenti, M. A. Donati, and E. Zammarchi Rapid 2nd-Tier Test for Measurement of 3-OH-Propionic and Methylmalonic Acids on Dried Blood Spots: Reducing the False-Positive Rate for Propionylcarnitine during Expanded Newborn Screening by Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., July 1, 2007; 53(7): 1364 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Leight The Physical, Emotional, and Financial Trauma Incurred by Infants and Their Families When an Existing Condition Is Not Detected by Newborn Screening Pediatrics, October 1, 2006; 118(4): 1801a - 1802. [Full Text] [PDF] |
||||
![]() |
S. E. Waisbren Newborn screening for metabolic disorders. JAMA, August 23, 2006; 296(8): 993 - 995. [Full Text] [PDF] |
||||










